"Revolutionary Single-Dose Gene Therapy Transforms Lives of Hereditary Angioedema Patients"
TL;DR
A single-dose gene therapy using CRISPR has shown promising results in treating hereditary angioedema, a rare genetic disorder causing painful and potentially fatal swelling. Patients in a human trial reported dramatic improvements in their health and quality of life, with some describing it as a "medical magic wand." The treatment corrects the C1 kallikrein gene and has the potential to transform the lives of those affected by the condition, although it comes with a high cost.
Topics:healthhealth-medical-breakthrough#clinical-trials#crispr#gene-therapy#health-medical-breakthrough#hereditary-angioedema#medical-innovation
- Single-Dose of Gene Therapy Hailed as 'Magic Wand' for Patients with Deadly Condition, Transforming Lives Good News Network
- CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema | NEJM nejm.org
- CRISPR gene therapy seems to cure dangerous inflammatory condition New Scientist
- Angiodema: Gene therapy blocks painful hereditary disorder BBC.com
- Gene therapy hailed as ‘medical magic wand’ for hereditary swelling disorder The Guardian
Want the full story? Read the original reporting
Read on Good News Network